NCT01796899

Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers

A Randomized, Single-center, Open-label, 5-way Crossover, Single-dose Bioavailability/Bioequivalence Comparison of Brivaracetam Oral Tablets (10 mg, 50 mg,75 mg, and 100 mg) and Brivaracetam Intravenous Bolus Injection (100 mg) in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: UCB Pharma SA · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To investigate the bioavailability/bioequivalence of Brivaracetam oral tablets (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam intravenous injection (100 mg) in healthy volunteers.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
OTHER	Brivaracetam 10 mg oral tablet
OTHER	Brivaracetam 50 mg oral tablet
OTHER	Brivaracetam 75 mg oral tablet
OTHER	Brivaracetam 100 mg oral tablet
OTHER	10 mL of Brivaracetam intravenous bolus injection (10 mg/mL)

Timeline

• Start date: 2013-01-01
• Primary completion: 2013-03-01
• Completion: 2013-03-01
• First posted: 2013-02-22
• Last updated: 2013-04-15

Locations

1 site across 1 country: Netherlands